CGM Use in Heart Failure
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 140 participants.
Also called NCT07045298
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 140 participants
- Registry
-
NCT07045298
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07045298. Randomized; no masking; primary purpose diagnostic. Start 2026-11 (anticipated); primary completion 2027-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CGM Use in Heart Failure
- Condition
- Heart Failure
- Condition
- Diabetes Mellitus
- Intervention (Device)
- Libre 2 rt-CGM
- Intervention (Diagnostic test)
- POC BG + Blinded CGM
- Lead sponsor
- Emory University
- Collaborator
- American Heart Association
- Collaborator
- Abbott Diabetes Care
Record details
- Record id
cardio:ct-nct07045298- Content hash
48431772ca0e5b3129e7a59c7ce33619d7a00406bf8257a181ec22f7648da8cd